Skip to main content

Acute Pulmonary Embolism: Hemodynamic Aspects and Treatment

  • Chapter
Book cover Perioperative and Critical Care Medicine
  • 147 Accesses

Abstract

Pulmonary embolism (PE) is a major international health problem, with an annual estimated incidence of over 100,000 cases in France, 65,000 cases among hospitalized patients in England and Wales, and at least 60,000 new cases per year in Italy. The diagnosis is often untreated, difficult to obtain and is frequently missed [1]. Mortality in the untreated is approximately 30%, but with adequate treatment this can be reduced to 2–8%. Numerous cases go unrecognized and hence untreated, with poor outcomes. Indeed the prevalence of PE at autopsy (approximately 12–15% in hospitalized patients) has not changed over three decades [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (2000) Task force on Pulmonary Embolism. European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heat J 21:1301–1336

    Google Scholar 

  2. Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital at autopsy. Chest 108:78–81

    Article  Google Scholar 

  3. Morpurgo M, Rustici A (1988) Lo spettro dell’embolia polmonare. Cardiologia 33:1105–1108

    CAS  PubMed  Google Scholar 

  4. Morpurgo M, Schmid C (1980) Clinic-pathologic correlations in pulmonary embolism: a posteriori evaluation. Prog Res Dis 13:8–15

    Google Scholar 

  5. Pacouret G, Alison D, Pottier JM et al (1997) Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: a prospective study. Arch Intern Med 157:305–308

    Article  CAS  PubMed  Google Scholar 

  6. Barrit DW, Jordan SC (1961) Clinical features of pulmonary embolism. Lancet 1:729–739

    Article  Google Scholar 

  7. Goldhaber SZ, Hennekens CH, Evans D et al (1982) Factors associated with corrected antemortem major of pulmonary embolism. Am J Med 73:822–826

    Article  CAS  PubMed  Google Scholar 

  8. Kasper W, Konstantinides S, Tiede N et al (1997) Prognostic significance of right ventricular afterload stress detected by echocardiography in patient with clinically suspected pulmonary embolism. Heart 77:346–349

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Ribeiro A, Lindmarker P, Jublin-Dannfelt A et al (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality. Am Heart J 134:479–487

    Article  CAS  PubMed  Google Scholar 

  10. Konstantinides S, Geribel A, Kasper W et al (1988) Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 97:1946–1951

    Article  Google Scholar 

  11. Sasahara AA, Maclntyre KM, Cella G et al (1988) The clinical and the hemodynamic feature of pulmonary embolism. Curr Pulmonol 9:305–346

    Google Scholar 

  12. Kenneth E, Wood DO (2002) Review of a pathophysiologic apport to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905

    Article  Google Scholar 

  13. McIntyre KM, Sasahara AA (1974) Determinants of right ventricular function and haemodynamics after pulmonary embolism. Chest 65:534–643

    CAS  PubMed  Google Scholar 

  14. Mclntyre KM, Sasahara AA (1974) Hemodynamic and ventricular responses to pulmonary embolism. Prog Cardiovasc Dis 17:175–190

    Article  Google Scholar 

  15. Benis CE, Serur JR, Borkenaghen D et al (1974) Influence of right ventricular filling pressure on left ventricular pressure and dimission. Circ Res 34:498–504

    Article  Google Scholar 

  16. Menzel T, Wagner S, Kramm T et al (2000) Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension. Chest 118:897–903

    Article  CAS  PubMed  Google Scholar 

  17. Belenkie I, Dani R, Smith ER, Tyberg JV (1988) Ventricular interaction during experimental acute pulmonary embolism. Circulation 78:761–768

    Article  CAS  PubMed  Google Scholar 

  18. Adam JE, Siegel BA, Goldstein et al (1992) Elevation of CK-MB following pulmonary embolism. Chest 101:1203–1236

    Article  Google Scholar 

  19. Ramirez-Rivera A, Gutiérrez-Fajardo P, Jerjez-Sanchez C et al (1993) Acute right myocardial infarction without significant obstructive coronary lesions secondary to massive pulmonary embolism. Chest 104:80S

    Google Scholar 

  20. Konstantinides S, Geibel A, Olschewski M et al (2002) Importance of toponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106:1263–1268

    Article  CAS  PubMed  Google Scholar 

  21. Manier G, Castaing Y, Guenard H (1985) Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. Am Rev Respir Dis 132:332–338

    CAS  PubMed  Google Scholar 

  22. Krivec B, Voga G, Zuran I et al (1997) Diagnosis and treatment of shock due to massive pulmonary embolism. Approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 112:1310–1316

    CAS  Google Scholar 

  23. Palla A, Petruzzelli S, Donnamaria V et al (1995) The role of suspicion in the diagnosis of pulmonary embolism. Chest 107:21S–24S

    Article  CAS  PubMed  Google Scholar 

  24. Kohen H, Koenig B, Mostbeck A (1987) Incidence and clinical feature of pulmonary embolism in patients with deep vein thrombosis: a prospective study. Eur J Nucl Med 13:S11–S15

    Google Scholar 

  25. Kakkar VV, Flanc C, Howe CT, Clarke MB (1969) Natural history of postoperative deep-vein thrombosis. Lancet 2:230–232

    Article  CAS  PubMed  Google Scholar 

  26. Mathru M, Venus B, Smith R et al (1986) Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goals. Crit Care Med 14:120–124

    CAS  PubMed  Google Scholar 

  27. Ducas J, Prewitt RM (1987) Pathophysiology and therapy of right ventricular dysfunction due to pulmonary embolism. Cardiovasc Clin 17:191–202

    CAS  PubMed  Google Scholar 

  28. Prewitt RM (1997) pharmacological hemodynamic support in massive pulmonary embolism. Chest 111:218–224

    Article  Google Scholar 

  29. Mercat A, Diehl JL, Meyer G et al (1999) Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27:540–544

    CAS  PubMed  Google Scholar 

  30. Ghignone M, Girling L, Prewitt RM (1984) Volume expansion versus nore-phinephrine in treatment of a low cardiac output complicating an acute in righr ventricular afterloads in dogs. Anesthesiology 80:132–135

    Article  Google Scholar 

  31. Molloy DW, Lee KY, Jones D et al (1985) Effects of noradrenaline and isoproterenol on cardio-pulmonary function in a canine model of acute pulmonary hypertension. Chest 88:432–435

    Article  CAS  PubMed  Google Scholar 

  32. Angle MH, Molloy DW, Penner B et al (1989) The cardiopulmonary and renal hemo-dynamc effects of norephinephrine in canine pulmonary embolism. Chest 95:1333–1337

    Article  CAS  PubMed  Google Scholar 

  33. Wolfe MW, Saad RM, Spence TH (1992) Hemodynamic effects of amrinone in a canine model of massive pulmonary embolism. Chest 102:274–278

    Article  CAS  PubMed  Google Scholar 

  34. Hill NS, Rounds S (1983) Amrinone dilates pulmonary vessels and blunts hypoxic vasoconstriction in isolated rat lungs. Proc Soc Exp Biol Med 173:205–212

    Article  CAS  PubMed  Google Scholar 

  35. Manier G, Castaing Y (1992) Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis 145:130–136

    Article  CAS  PubMed  Google Scholar 

  36. Jardin F, Genevray B, Brun-Neg D et al (1985) Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 13:1009–1012

    CAS  PubMed  Google Scholar 

  37. Layish DT, Tapson VF (1997) Pharmacological hemodynamic support in massive pulmonary embolism. Chest 111:218–224

    Article  CAS  PubMed  Google Scholar 

  38. Triantafillou AN, Pohl MS, Okabayashi K et al (1995) Effect of inhaled nitric oxide and prostaglandin E1 on hemodynamic and arterial oxygénation in patients following single lung transplantation. Anesth Analg 8o:SCA 40

    Google Scholar 

  39. Walmrath D, Schermuly R, Pilch J et al (1997) Effect of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J 10:1084–1092

    Article  CAS  PubMed  Google Scholar 

  40. Brienza A (1999) Strategies on management of pulmonary hypertension. Minerva Anestesiol 65:769–773

    CAS  PubMed  Google Scholar 

  41. Capellier G, Jacques T, Balay P et al (1997) Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1089–1092

    Google Scholar 

  42. Vizza CD, Della Rocca G, Di Roma A et al (2001) Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of two in patients with mild to moderate secondary pulmonary hypertension. Critical Care 5:355–361

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Haraldsson A, Kieler-Jensen N, Ricksten SE et al (1996) Inhaled prostcyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10:864–868

    Article  CAS  PubMed  Google Scholar 

  44. Olschewski H, Gofrani HA, Walmarath D et al (1999) Inhaled prostcyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 160:600–607

    CAS  PubMed  Google Scholar 

  45. Mirza I, Nagamine J, Pearl RG (1997) Additive effects of inhaled prostacyclin and inhaled nitric oxide in reducing experimental pulmonary hypertension. Anesthesiology 87:1122

    Article  Google Scholar 

  46. Hill LL, Pearl RG (1999) Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension. J Appl Physiol 86:1160–1164

    CAS  PubMed  Google Scholar 

  47. Della Rocca G, Coccia C, Pompei L et al (2001) Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled areosolized prostacyclin. J Cardiothorac Vasc Anesth 15:224–227

    Article  Google Scholar 

  48. Ginsberg JS (1996) Management of venous thromboembolism. N Engl J Med 335:1816–1828

    Article  CAS  PubMed  Google Scholar 

  49. Goldhaber SZ (1998) Pulmonary Embolism. New Engl J Med 339:93–104

    Article  CAS  PubMed  Google Scholar 

  50. Hyers TM, Russell DH, Weg JG (1995) Antithrombotic therapy for venous throm-boembolic disease. Chest 108:335S-351S

    Google Scholar 

  51. Shulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulation therapy after a first episode of venous thrrom-boembolism. N Eng J Med 332:1661–1665

    Article  Google Scholar 

  52. Ahearn GS, Hadjiadis D, Govert JA et al (2002) Massive pulmonary embolism during pregnancy succesfully treated with recombinant tissue plasminogen activator. A case report and review of treatment options. Arch Int Med 162:1221–1227

    Google Scholar 

  53. Hamel E, Pacouret G, Vinentelli D et al (2001) Thrombolysis or heparin therapy in massive pulmoanry embolism with right ventricular dilation. Chest 120:120–125

    Article  CAS  PubMed  Google Scholar 

  54. Konstantinides S, Geibel A, Olschewski M et al (1997) Association between throim-bolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation 96:882–888

    Article  CAS  PubMed  Google Scholar 

  55. Arcaoy Sm, Kreit JW (1999) Thrombolytic therapty of pulmonary embolism. Chest 115:1695–1707

    Article  Google Scholar 

  56. Sors H, Pacouret G, Azarian R, Meyer G et al (1994) Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 106:712–717

    CAS  Google Scholar 

  57. Wood KE (2002) Major pulmonary embolism. Review of a patophysiologic approach to the Golden Hour of hemodynamically significant pulmoanry embolism. Chest 121:877–905

    Google Scholar 

  58. Girard P, Stern JB, Parent F (2002) Medical literature and the Vena Cava filters. Chest 122:963–967

    Article  PubMed  Google Scholar 

  59. (1999) Participants in the Vena Cava Filter Consensus Conference. Recommended reporting standards foe vena cavai filter placement and patients follow-up. J Vasc Surg 30:573–579

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Italia

About this chapter

Cite this chapter

Della Rocca, G., Coccia, C., Reffo, I. (2004). Acute Pulmonary Embolism: Hemodynamic Aspects and Treatment. In: Gullo, A., Berlot, G., Lucangelo, U., Pellis, T. (eds) Perioperative and Critical Care Medicine. Springer, Milano. https://doi.org/10.1007/978-88-470-2135-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2135-8_16

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0278-4

  • Online ISBN: 978-88-470-2135-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics